Where I see patients (1)
My work
Cutting-edge breast cancer care
Learn about the latest findings on breast cancer risk, screening and treatment from Dr. Esserman.
Should low-risk tumors still be called cancer?
Dr. Esserman explains how using a different term could reduce unnecessary worry over cancers that are unlikely to be life-threatening.
My reviews
Selected research
-
National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling.
BMJ open
-
A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer.
NPJ breast cancer
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
Annals of surgical oncology
Contact me
- Request appointment
- Refer a patient
- (415) 353-7070
4.8